Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DERMAGEN vs conventional treatment for diabetic neuropathic foot ulcers
2009-014276-22Phase 3Terminated
- Sponsor
- Laboratoires Genevrier
- Start
- Sep 2009
- Modality
- Cell Therapies, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Dermagen in diabetic foot ulcer (DFU) (2 arms), sponsored by Laboratoires Genevrier. Primary endpoint: Healing rate at week 12. Started Sep 2009; status: terminated.
02
Drugs
Dermagen
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2009-014276-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014276-22.